Pepteeva Health

The official domain reaches a branded Beyond portal. Linked terms identify WHOOSH HOLDING CO LLC DBA WHOOSH WELLNESS as the platform operator; they do not establish a separate Pepteeva legal operator.

Named operator, an attributed physical business address and a working-purpose contact telephone. Distinguish registered or correspondence offices from clinical and dispensing locations; online care does not require a walk-in clinic. Weight: 8%.

The linked platform FAQ describes intake review and a patient portal. The legal operator of Pepteeva itself, individual clinicians and their state credentials have not been established.

Who the service is for, prescribing or research-use boundaries, and provider information. Weight: 5%.

An example BPC-157 listing on the linked platform offers USD 199 monthly, 499 for three months or 949 for six months; the advertised 158/month is the six-month equivalent. This is platform example pricing, not a verified all-inclusive Pepteeva quote or a guarantee of eligibility.

Public prices or a defined quotation process, with recurring or additional charges explained. Weight: 5%.

The linked platform terms describe renewals, cancellation before the next cycle and restrictions on prescription refunds. They are platform terms; a separate Pepteeva operating entity or contract was not established.

Accessible cancellation, refund or ordering terms and a support channel. Weight: 4%.

The linked platform describes pharmacy standards without naming dispensing businesses. No particular supplier, active state credential or patient prescription assignment can be matched.

Named dispensing partners for care services; analytical documentation or manufacturing information for research businesses. Weight: 10%.

An entity-specific regulatory assessment has not been completed. No clean record or adverse finding is inferred.

Entity/product-specific regulatory notices, enforcement, recalls and their resolution, with dates and jurisdiction. A pharmacy license match alone is not a regulatory-history review. No clean record is inferred from silence. Weight: 10%.

This criterion has not yet been established from the reviewed evidence.

Product- and lot-specific laboratory reports covering molecule identity and purity, with the laboratory, report date and issuer authenticity check. Full credit requires independently established laboratory identity and a traceable verified report. A testing policy or a report for another batch provides limited evidence only; purity does not establish sterility, endotoxin control or treatment safety. Weight: 12%.

This criterion has not yet been established from the reviewed evidence.

An applicable external accreditation, such as LegitScript for healthcare, matched to the exact business or domain in the issuer’s records. A badge alone does not establish current certification. Weight: 3%.

This criterion has not yet been established from the reviewed evidence.

Accessible privacy terms identifying the responsible entities, data uses and applicable health-data notice. A HIPAA claim is not independent verification of compliance; HIPAA is not required of every research business. Weight: 6%.

This criterion has not yet been established from the reviewed evidence.

Specific, dated evidence of relevant security practices or an independently issued audit, with its entity, scope and limits. HTTPS, a marketing seal or a claim of being unhackable is insufficient. Weight: 6%.

This criterion has not yet been established from the reviewed evidence.

Disclosed payment processing, billing authorization and recurring-charge arrangements. No processor brand is preferred and a processor does not certify the provider’s clinical or product quality. Weight: 3%.

This criterion has not yet been established from the reviewed evidence.

Clear product identity and intended use, distinguishing branded medicines, compounded preparations and research materials; presentation and preparation requirements where relevant. A compounded product is not assumed to be an approved generic. Weight: 8%.

This criterion has not yet been established from the reviewed evidence.

Product-specific delivery, temperature and storage instructions, including handling of shipping problems. Refrigeration, freezing or a particular presentation receives no automatic quality bonus. Weight: 5%.

The linked platform describes 503A/503B pharmacy standards without identifying dispensing businesses. These general statements do not establish which pharmacy serves Pepteeva or an active state-license match.

At least one exactly named dispensing partner matched to an active, unreplaced official state record. This does not verify all partners or all jurisdictions. Weight: 15%.